Revisiting the combinatorial potential of cytokine subunits in the IL-12 family
- 1 July 2019
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 165, 240-248
Abstract
No abstract availableKeywords
Funding Information
- Flanders Agency for Innovation and Entrepreneurship
- Research Foundation FlandersResearch Foundation Flanders (G0E1516N, G0B4918N)
- Hercules Foundation (AUGE-11-029)
This publication has 41 references indexed in Scilit:
- Cytokine-like factor 1 (CLF1): Life after development?Cytokine, 2011
- Therapeutic targeting of the IL-12/23 pathways: generation and characterization of ustekinumabNature Biotechnology, 2011
- IL-17 and Th17 CellsAnnual Review of Immunology, 2009
- The inhibitory cytokine IL-35 contributes to regulatory T-cell functionNature, 2007
- IL-12p40: an inherently agonistic cytokineTrends in Immunology, 2007
- A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease GeneScience, 2006
- Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune InflammationJournal of Experimental Medicine, 2003
- IL-27, a Heterodimeric Cytokine Composed of EBI3 and p28 Protein, Induces Proliferation of Naive CD4+ T CellsImmunity, 2002
- A bioactive designer cytokine for human hematopoietic progenitor cell expansionNature Biotechnology, 1997
- Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.Journal of Experimental Medicine, 1989